History of Evolution of Ethical Guidelines and Clinical Research Regulations

Size: px
Start display at page:

Download "History of Evolution of Ethical Guidelines and Clinical Research Regulations"

Transcription

1 History of Evolution of Ethical Guidelines and Clinical Research Regulations Dr P Paul Kumaran MBBS, BA (Psychology), MPH Scientist E [Deputy Director Medical] National Institute for Research in Tuberculosis (ICMR) Madurai, Tamil Nadu, India ppaulkumaran@nirt.res.in

2 Can you tell me, Socrates, whether virtue is acquired by teaching or by practice, or if neither, then whether it comes to man by nature, or in what other way? I do not even know what virtue is, much less how it is acquired Ref: Plato - Dialogues Socrates (469/ BCE) was a Greek philosopher and is considered the father of western philosophy; Plato was his most famous student

3 Synonym: Definition: Context: Relevance: Ethics: What is it? Moral Philosophy Systematizing, defending, and recommending concepts of right and wrong behaviour Geographic & Cultural Medicine, Public Health & Research It is the science of morality grammar of one s behaviour affecting others (Universal fact that all human beings are vulnerable, can suffer from harm and cause harm) Humans being fallible educating is not guaranteed success

4 30 th Century BC Siddha 10 th Century BC 200 AD: Caraka saṃhitā (written code on Ayurveda - Indian traditional medicine) 4 th Century BC: Hippocratic Oath 1-2 nd Century AD: Code of Hammurabi (Babylonian law code of ancient Mesopotamia) Primum non nocere DO NO HARM

5 Bio-Medical Ethics? Clinical Ethics Service related provider / patient relationship (social) Targets service providers Code of Conduct Research Ethics Research with special reference to commercialized research vested interest of sponsor / investigator Targets supervision / monitoring of conduct of research

6 Questions? Comments!!!

7 Why Ethics? History

8 Landmark Article on US Abuses Henry Beecher NEJM, 1966

9 Why Ethics? History

10 Ethical Principles and Guidelines for the Protection of Human Subjects of Research National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research April 18, 1979

11 Why Ethics? History

12 Questions? Comments!!!

13 Relationship Definitions Ref: Oxford English Dictionary 2001 Principles A general truth that is used as a basis for a theory or system of belief for governing one s personal behaviour Guidelines A piece of advice or an indication as to how something should be done Regulations Law: A rule/system of rules made by an authority, recognized by a country / community as governing actions of its members that controls correct behaviour Rule: A statement of code of practice and discipline that must be done or not done for control of a group, community, or country

14 Bioethics What are the basic principles? Beneficence & Non-maleficence Do GOOD and Do NO HARM Double Effect or Combined Effect Autonomy Respect for persons Conflicts between Autonomy & Beneficence Justice Fairness, equal distribution of risks & benefits Ultimate AIM: Human participant protection

15 Principles little elaborate Beneficence and Non-malficence Identification of Risks minor / major Risk Minimization Benefits direct / indirect / no benefit / society Appropriate Risk vs Benefit ratio Respect for individuals Informed Consent / Protection of Vulnerable people Privacy and Confidentiality Justice Equitable selection / Equal distribution of burdens and benefits Post trial benefits / prior agreements

16 Public Health Ethics: Principles General principles: Beneficence, Non-maleficence, Respect for individuals (Personalistic principle), & Justice Harm principle: exercising power over an individual (against will), to prevent harm to others (John Stuart Mill) Principle of Least Restrictive / Coercive Means: more coercive methods employed only on failure of less coercive means, provided legal & necessary (Siracusa principle)

17 Public Health Ethics: Principles Reciprocity principle: society must facilitate PH in their efforts to discharge their duties (Harris & Holm) Transparency principle: Decision making must involve all legitimate stakeholders & must be clear and accountable Ref: Upshur Principles for the justification of public health intervention Canadian Journal of Public Health 2002; 93 (2):

18 Bioethics Guidelines Ethical Guidelines for Biomedical Research on Human Participants (Feb 1980, rev Sept 2000, rev 2006, ) Good Clinical Practices: Guidelines for Clinical Trials on Pharmaceutical products in India, 2001 National Guidelines for Accreditation, Supervision & Regulation of ART Clinics in India, 2005 Ethical Guidelines for Bio-banking in India, 2006 Guidelines for Stem Cell Research & Therapy, 2007

19 India - Guidelines Guidelines for Stem Cell Research And Therapy Department of Biotechnology and Indian Council of Medical Research Department of Health Research 2007

20 Questions? Comments!!!

21 Bioethics Laws and Rules Drugs and Cosmetics Act (DCA) 1940 & Rules , Schedule Y 1988, amendments 2005, 2011, 2013 Code of Medical Ethics Regulations Professional Conduct, Etiquette, & Ethics for RMPs 1956, rev 2002, amended 2003, 2004, 2009 Duties of Physicians 8 chapters General, towards patients, consulting process, peers, public Unethical acts, misconduct, punishment/disciplinary action Prevention of Cruelty to Animals Act (PCA Act) 1960 (59 of 1960) (Animal Welfare Board of India) Breeding of and Experiments on Animals Rules, 1998 (Ministry of Environment and Forests) Amendment Rules, 2001 & 2006

22 Regulations: evolution (Manufacture and Sale of drugs in India) Beginning 20 th century - no drug industry in INDIA drugs imported for use During I World War Pharmaceuticals manufacturing drugs Glamour for swadeshi goods No specific laws or rules to govern import of drugs or to ensure uniform quality of manufactured drugs Reports of poor quality drugs being freely available Government felt the need for comprehensive legislation Drugs enquiry committee in Chopra Committee Committee s report, GOI passed the Drugs Act in 1940 to regulate import, manufacture, distribution, and sale of drugs

23 Drugs and Cosmetics Act Divided in Chapters, Rules, and Schedules to cover all aspects related to drug regulation Regulation of manufacture, sale and distribution of drugs - State authorities Approval of New Drugs, Clinical Trials, laying down standards for Drugs, control over the quality of imported Drugs Central authorities CDSCO Central Drugs Standard Control Organization through DCGI regulatory body

24 Schedule Y 1988, CDSCO added Schedule Y to the DCA 1940 Mandatory for pharmaceutical companies to demonstrate safety and efficacy of a new drug before obtaining a license DCA 1940 (23 of 1040), Schedule Y (1988) Rules 122A, 122B, 122D, 122DA, 122DAA and 122E: Requirements and guidelines for Permission to Import and/or Manufacture of New drugs for sale or Undertake Clinical Trials Schedule Y Amendment 2005 (20 th January 2005) DCA Amendment 2013 (29 th August 2013)

25 Further Evolution!!! India joined World Trade Organization (WTO) 1995: Signatories have to protect product patents Full compliance with product patent regimen in 2005 Amendment of the DCA 1940 in 2005 Permitted Industry to (i) repeat Phase I trials in India (ii) commence Phase II trials in conjunction with same trials at other sites India: an attractive destination for clinical research

26 Clinical trial: concerns The protection of the rights, safety, and wellbeing of the research participants Interesting disease profile in India High burden of infectious communicable and non communicable diseases Rising prevalence of chronic life-style diseases Presence of a vast treatment-naïve population Adequate manpower and infrastructure at lower cost Ensuring the quality & integrity and accuracy & validity of the data obtained from clinical research

27 Circular by Deputy Director, Tribal Welfare Department authorizing Warden / Head of school to give consent for residents Parents gave consent for non-residents but were ignorant of consequences Captive vulnerable participants - Tribal minor girls in Hostel Misconception public immunization program, vaccine free of cost No institutional ethics committee review

28 Amendment Rules Drugs and cosmetics (first amendment) rules, 2013 Gazette notification G.S.R. 53(E), 30 Jan 2013 & (sixth amendment) rules, 2014 Gazette notification GSR 889 (E), 12 Dec 2014 Rule 122DAB: Compensation in case of injury / death during clinical trial Drugs and cosmetics (second amendment) rules, 2013 Gazette notification G.S.R. 63(E), 1 Feb 2013 Rule 122DAC: Permission to conduct clinical trial (SAE reporting) Drugs and cosmetics (third amendment) rules, 2013 Gazette notification G.S.R. 72(E), 8 Feb 2013 Rule 122DD: Registration of Ethics Committees Drugs and cosmetics (second amendment) rules, 2013 Gazette notification G.S.R. 364(E), 7 June 2013 Draft Rules: Audio-video recording of informed consent process DCGI Order dated 19 Nov 2013 (in addition to obtaining written IC)

29 What needs to be done?

30 Questions? Comments!!!

31 Thank You

Biomedical Research on Human Participants

Biomedical Research on Human Participants Ethical Guidelines for Biomedical Research on Human Participants Dr P Paul Kumaran MBBS, BA (Psychology), MPH Scientist E [Deputy Director Medical] National Institute for Research in Tuberculosis (ICMR)

More information

Regulations & Guidelines Specific to Ethics Schedule Y & CDSCO-GCP

Regulations & Guidelines Specific to Ethics Schedule Y & CDSCO-GCP Regulations & Guidelines Specific to Ethics Schedule Y & CDSCO-GCP Dr. K. Bangarurajan M Pharm, PhD Deputy Drugs Controller (India) CDSCO West Zone Outline Licensing Authority India - Clinical Trial: CDSCO

More information

Clinical Research: A Multifaceted Discipline

Clinical Research: A Multifaceted Discipline Clinical Research: A Multifaceted Discipline Anuradha Kulkarni a, Arun Bhatt b* a Senior Associate - Medical & Regulatory Affairs, Clininvent Research Pvt Ltd, A-302, Everest Chambers, Marol Naka, Andheri

More information

Mohammed Al Jumah. King Abdullah International Medical Research Center KSAU-HS NGHA

Mohammed Al Jumah. King Abdullah International Medical Research Center KSAU-HS NGHA Mohammed Al Jumah King Abdullah International Medical Research Center KSAU-HS NGHA Introduction Research Ethics NCBE Research & Ethics Interactions Clinical practice and Research Fair Access of research

More information

Clinical Trials in India Regulatory Issues

Clinical Trials in India Regulatory Issues Clinical Trials in India Regulatory Issues Prem Pais MD Dean & Professor of Medicine St. John s Medical College Head, Clinical Trials Division St. John s Institute of Population Health and Clinical Research

More information

MEDICAL ETHICS: INTRODUCTION AND HISTORY OF BIOETHICS

MEDICAL ETHICS: INTRODUCTION AND HISTORY OF BIOETHICS MEDICAL ETHICS: INTRODUCTION AND HISTORY OF BIOETHICS DR.MAHJABEEN KHAN Assistant Professor MCPS, MS, MHSc in Bioethics (Canada) Research Department, Clinical Trials Unit DUHS LEARNING OBJECTIVES At the

More information

An exploration of the Contract Research Organisation sector in. Divya Bhagianadh

An exploration of the Contract Research Organisation sector in. Divya Bhagianadh An exploration of the Contract Research Organisation sector in India Divya Bhagianadh Global scenario Outsourcing clinical trials- the new trend Estimated CRO market revenues 2000-2010e ($ bn) Total market

More information

Pre-Screening revised checklist for BA/BE NOC for Export Purpose

Pre-Screening revised checklist for BA/BE NOC for Export Purpose Pre-Screening revised checklist for BA/BE NOC for Export Purpose O/o Drugs Controller General (India) Directorate General of Health Services FDA Bhawan, New Delhi (With effective from 25 th April 2014)

More information

How did it evolve? o Public disasters, serious fraud and abuse of human rights. o Trials of War criminals-nuremberg code 1949

How did it evolve? o Public disasters, serious fraud and abuse of human rights. o Trials of War criminals-nuremberg code 1949 ICH GCP Overview What is ICH? ICH is a joint initiative involving both the regulators and the industry as equal partners in the scientific and technical discussions of the testing procedures which are

More information

Ethics Committees/IRBs Today: Challenges for Efficiency and Quality

Ethics Committees/IRBs Today: Challenges for Efficiency and Quality Marjorie A. Speers, Ph.D. President and CEO Ethics Committees/IRBs Today: Challenges for Efficiency and Quality Copyright 2013 AAHRPP All rights reserved Goal Clinical Research Globally Access to patients

More information

Ethical Principles in Clinical Research

Ethical Principles in Clinical Research Ethical Principles in Clinical Research Christine Grady NIH Clinical Center Department of Bioethics No conflicts of interest. Views presented are mine and do not necessarily represent positions or policies

More information

NHS Research Ethics Approval the process

NHS Research Ethics Approval the process NHS Research Ethics Approval the process Dr Sheila A Simpson 27 May 2008 ETHICS The process of determining what is right and wrong Personal code of conduct based on respect for one's self, others, and

More information

3. Human Biomedical Research. Defining Human Biomedical Research

3. Human Biomedical Research. Defining Human Biomedical Research PART B: SECTION III: HUMAN BIOMEDICAL RESEARCH HUMAN BIOMEDICAL RESEARCH 3. Human Biomedical Research Defining Human Biomedical Research 3.1. In this section, we consider what kinds of human biomedical

More information

INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience

INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience Umberto Filibeck Former Head of AIFA GCP Inspectorate and GCP Promotion Unit UNICRI Consultant for Projects on GCP of CTs in developing

More information

CENTRAL DRUGS STANDARD CONTROL ORGANIZATION DIRECTORATE GENERAL OF HEALTH SERVICES MINISTRY OF HEALTH AND FAMILY WELFARE GOVERMENT OF INDIA

CENTRAL DRUGS STANDARD CONTROL ORGANIZATION DIRECTORATE GENERAL OF HEALTH SERVICES MINISTRY OF HEALTH AND FAMILY WELFARE GOVERMENT OF INDIA 1 GUIDANCE DOCUMENT FOR BA/BE NOC FOR EXPORT CENTRAL DRUGS STANDARD CONTROL ORGANIZATION DIRECTORATE GENERAL OF HEALTH SERVICES MINISTRY OF HEALTH AND FAMILY WELFARE GOVERMENT OF INDIA GUIDANCE DOCUMENT

More information

Volunteering for Clinical Trials

Volunteering for Clinical Trials Volunteering for Clinical Trials Volunteering for Clinical Trials When considering volunteering for a clinical trial, it is important to make an informed decision. Below are answers to frequently asked

More information

Human Subjects Protection: Training for Research Teams

Human Subjects Protection: Training for Research Teams Human Subjects Protection: Training for Research Teams Walter L. Calmbach MD MPH South Texas Ambulatory Research Network (STARNet) Dept. of Family & Community Medicine Univ. of Texas Health Science Center

More information

Institutional Review Board

Institutional Review Board Institutional Review Board Overview & Minimal Risk Research Jon Mark Hirshon, MD, MPH Vice-Chairman University of Maryland Institutional Review Board May 18, 2006 Jon Mark Hirshon, MD, MPH 1 Presentation

More information

TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH

TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH Investigators Responsibility #1: Design and Implement Ethical Research Consistent with the Three Ethical Principles Delineated in The Belmont Report. The Belmont Report: Three Basic Ethical Principles:

More information

Standards of proficiency. Biomedical scientists

Standards of proficiency. Biomedical scientists Standards of proficiency Biomedical scientists Contents Foreword 1 Introduction 3 Standards of proficiency 7 Foreword We are pleased to present the Health and Care Professions Council s standards of proficiency

More information

June 14, To the World Medical Association Secretariat:

June 14, To the World Medical Association Secretariat: June 14, 2013 To the World Medical Association Secretariat: The following are the comments from the Executive Committee of the Latin American and Caribbean Network of Bioethics UNESCO 1 to the draft of

More information

ICMR Ethical Guidelines for Biomedical Research in India

ICMR Ethical Guidelines for Biomedical Research in India ICMR Ethical Guidelines for Biomedical Research in India Dr. Roli Mathur Scientist D Program Officer for Bioethics, Animal Ethics, Human Genetics, Anthropology, Anatomy, Hematology, Short Term Studentship

More information

Ethical, Legal and Social Issues arising out of Advancements in New Biology. Seyed E. Hasnain

Ethical, Legal and Social Issues arising out of Advancements in New Biology. Seyed E. Hasnain Ethical, Legal and Social Issues arising out of Advancements in New Biology Seyed E. Hasnain Importance of Ethics in Infectious Diseases/Clinical Research Ethics: separate right from wrong as a principle

More information

DRAFT SOCIAL SCIENCES STANDARDS: CIVICS AND GOVERNMENT

DRAFT SOCIAL SCIENCES STANDARDS: CIVICS AND GOVERNMENT DRAFT SOCIAL SCIENCES STANDARDS: CIVICS AND GOVERNMENT CORE STANDARDS Civics and Government 10. Examine the relationship between government and citizens to distinguish and evaluate the ways that civic

More information

Ethical Principles in Clinical Research. Disclaimer. Christine Grady Department of Bioethics NIH Clinical Center

Ethical Principles in Clinical Research. Disclaimer. Christine Grady Department of Bioethics NIH Clinical Center Ethical Principles in Clinical Research Christine Grady Department of Bioethics NIH Clinical Center Disclaimer The views expressed are mine and do not necessarily represent the positions or policies of

More information

Protection of Research Participants: The IRB Process and the Winds of Change

Protection of Research Participants: The IRB Process and the Winds of Change Protection of Research Participants: The IRB Process and the Winds of Change Ethics in Patient-Oriented Research October 12, 2011 Sharon Friend Director, OHRPP Overview Charge and Function of the IRB Quick

More information

SAE Reporting Timelines, Causality Assessment And Compensation. Pawandeep Kaur Associate Medical Director CDSA

SAE Reporting Timelines, Causality Assessment And Compensation. Pawandeep Kaur Associate Medical Director CDSA SAE Reporting Timelines, Causality Assessment And Compensation Pawandeep Kaur Associate Medical Director CDSA Objective Background Important definitions SAE Reporting Timelines Causality Assessment Compensation

More information

Ethics in Biomedical Research

Ethics in Biomedical Research EDUCATIONAL FORUM Ethics in Biomedical Research 1 Vina Vaswani, Vinodkumar C.S 1 2 2 Director, Centre of Ethics, Yenepoya University, Associate Professor, Department of Microbiology S.S Institute of Medical

More information

WCG ACADEMY COURSE OVERVIEW

WCG ACADEMY COURSE OVERVIEW WCG ACADEMY COURSE OVERVIEW Investigator Course Title Documentation of Informed Consent Duration Ethical Principles Underlying Consent Documentation Long Form Short Form Consent Records Special Considerations

More information

Standards of proficiency. Social workers in England

Standards of proficiency. Social workers in England Standards of proficiency Social workers in England Contents Foreword 1 Introduction 2 Standards of proficiency 6 Foreword We are pleased to present the Health and Care Professions Council s standards of

More information

Agenzia Italiana del Farmaco

Agenzia Italiana del Farmaco Agenzia Italiana del Farmaco The Italian Legislation and the work of the Italian Medicines Agency (AIFA) in the field of ethics of Clinical Trials Umberto Filibeck AIFA Head of GCP Inspectorate and GCP

More information

CODE OF PRACTICE FOR RESEARCH

CODE OF PRACTICE FOR RESEARCH CODE OF PRACTICE FOR RESEARCH Dr Diana Leighton REF Manager Professor Andy Young Director of Research & Innovation Services Version 1.0 - September 2010 First approved Academic Board 27 September 2010

More information

The$New$Ethics$of$Privacy

The$New$Ethics$of$Privacy The$New$Ethics$of$Privacy TRUST IN FINANCIAL SERVICES Source: 2015 Edelman Trust Barometer, available at http://www.edelman.com/insights/intellectualproperty/2015-edelman-trust-barometer/trustacross-industries/financial-services-path-tobuilding-trust/

More information

Institutional Review Board Compliance Elizabeth City State University

Institutional Review Board Compliance Elizabeth City State University Institutional Review Board Compliance Elizabeth City State University Michelle Moore, MBA Research Compliance Officer/IRB Administrator Office of Sponsored Programs, Contracts & Grants 110 McLendon Hall

More information

Regulatory system strengthening

Regulatory system strengthening SIXTY-SEVENTH WORLD HEALTH ASSEMBLY A67/32 Provisional agenda item 15.6 14 March 2014 Regulatory system strengthening Report by the Secretariat 1. The Executive Board at its 134th session noted an earlier

More information

H5PL 04 (SCDLMCS A1) Manage and Develop Yourself and Your Workforce Within Care Services

H5PL 04 (SCDLMCS A1) Manage and Develop Yourself and Your Workforce Within Care Services H5PL 04 (SCDLMCS A1) Manage and Develop Yourself and Your Workforce Within Care Services Overview This Unit is for leaders and managers of care services. It is about managing and developing yourself and

More information

GOOD SCIENTIFIC PRACTICE AND ETHICAL PRINCIPLES IN SCIENTIFIC RESEARCH AND HIGHER EDUCATION

GOOD SCIENTIFIC PRACTICE AND ETHICAL PRINCIPLES IN SCIENTIFIC RESEARCH AND HIGHER EDUCATION Central European Journal of Sport Sciences and Medicine : 2529 GOOD SCIENTIFIC PRACTICE AND ETHICAL PRINCIPLES IN SCIENTIFIC RESEARCH AND HIGHER EDUCATION Joanna Kruk Faculty of Physical Culture and Health

More information

Updating International Ethics Guidelines for Stem Cell Research

Updating International Ethics Guidelines for Stem Cell Research Updating International Ethics Guidelines for Stem Cell Research Jeremy Sugarman, MD, MPH, MA Harvey M. Meyerhoff Professor of Bioethics & Medicine Department of Medicine Berman Institute of Bioethics Johns

More information

50 SHADES OF GRAY: WHY AND WHEN IS IRB APPROVAL REQUIRED?

50 SHADES OF GRAY: WHY AND WHEN IS IRB APPROVAL REQUIRED? 50 SHADES OF GRAY: WHY AND WHEN IS IRB APPROVAL REQUIRED? Kevin L. Nellis, MS, CIP Executive Director, Human Research Protections and Quality Assurance Kathleen E. Powderly, CNM, PhD Director, John Conley

More information

WMA Declaration of Helsinki - Ethical

WMA Declaration of Helsinki - Ethical WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects Download the PDF file Adopted by the 18 th WMA General Assembly, Helsinki, Finland, June 1964 and amended

More information

S A I N T M A RY S E M I N A RY O C T O B E R 1 9,

S A I N T M A RY S E M I N A RY O C T O B E R 1 9, IRB BASICS FOR ADMINISTRATORS S A I N T M A RY S E M I N A RY O C T O B E R 1 9, 2 0 1 6 JOHN CARROLL UNIVERSITY Catherine Anson, MA, CRA, CIM Director of Sponsored Research Assistant IRB Chair Carole

More information

DEVELOPMENT OF CLINICAL BIOETHICS

DEVELOPMENT OF CLINICAL BIOETHICS DEVELOPMENT OF CLINICAL BIOETHICS CASES, COMMITTEES AND CONCEPTS Harvard Clinical Bioethics Course June 8, 2016 Christine Mitchell, RN Executive Director, Center for Bioethics, Harvard Medical School Concepts

More information

World Medical Association Declaration of Helsinki

World Medical Association Declaration of Helsinki World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects Adopted by the 18th WMA General Assembly Helsinki, Finland, June 1964 and amended by the

More information

Review PROCESS, decision making PROCESS and communication BY

Review PROCESS, decision making PROCESS and communication BY Review PROCESS, decision making PROCESS and communication BY ethics committee Dr. Reneega Gangadhar, Professor & Head Department of Pharmacology Govt. Medical college Trivandrum Outline Review process

More information

Regulatory and ethics bodies involved in approval process. CA - Submission for authorisation mandatory for

Regulatory and ethics bodies involved in approval process. CA - Submission for authorisation mandatory for Medicinal Products for Human Use - CZECH REPUBLIC Competent authority Contact Details Contact Name 1 State Institute for Control of Drugs- SÚKL (Státní ústav pro kontrolu léčiv) Phone +420 272 185 111

More information

INFORMATION ON JAPANESE REGULATORY AFFAIRS

INFORMATION ON JAPANESE REGULATORY AFFAIRS 2017 INFORMATION ON JAPANESE REGULATORY AFFAIRS Regulatory Information Task Force Japan Pharmaceutical Manufacturers Association Pharmaceutical Administration and Regulations in Japan Japan Pharmaceutical

More information

Reconsidering the Ethical Permissibility of the use of Unregistered Interventions against Ebola Virus Disease

Reconsidering the Ethical Permissibility of the use of Unregistered Interventions against Ebola Virus Disease Reconsidering the Ethical Permissibility of the use of Unregistered Interventions against Ebola Virus Disease Presented by: International Bioethics Retreat Paris, 2015 Dr. Thomas Foreman, MPIA, MA, DHCE

More information

Compliance mechanisms available in Russia to ensure adherence to ethical guidelines

Compliance mechanisms available in Russia to ensure adherence to ethical guidelines Compliance mechanisms available in Russia to ensure adherence to ethical guidelines Prof. Olga Kubar, Saint Petersburg Pasteur Institute, Russia 1 Project full title: Project acronym: Type of funding scheme:

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Ireland

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Ireland The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Ireland Question 1: What laws or regulations apply to an application for conducting a clinical

More information

Professional Capability Framework Social Work Level Capabilities:

Professional Capability Framework Social Work Level Capabilities: Professional Capability Framework Social Work Level Capabilities: This document presents the Social Work level Professional capabilities. The capabilities should be read in conjunction with the level descriptor

More information

LABORATORY TRAINING LOGBOOK

LABORATORY TRAINING LOGBOOK REGISTRATION TRAINING PORTFOLIO FOR THE IBMS CERTIFICATE OF COMPETENCE LABORATORY TRAINING LOGBOOK Version 4.1 www.ibms.org Trainee record details Registration Training Portfolio Case No: Surname: First

More information

Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines

Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines 1. Introduction The Canadian Cancer Clinical Trials Network (3CTN) will support a portfolio of academic clinical trials

More information

Chapter 3. Legal Construction of the Employment Environment 1/12/2009. Evolution of the Employment Relationship

Chapter 3. Legal Construction of the Employment Environment 1/12/2009. Evolution of the Employment Relationship Employment Law for Business, 6 th ed. Bennett-Alexander Chapter 3 Legal Construction of the Employment Environment Copyright 2007 by The McGraw-Hill Companies, Inc. All rights reserved. Evolution of the

More information

Business Ethics Concepts & Cases

Business Ethics Concepts & Cases Business Ethics Concepts & Cases Manuel G. Velasquez Chapter Eight Ethics and the Employee The Rational Model of a Business Organization Formal hierarchies identified in the organizational chart are the

More information

Standards of proficiency. Dietitians

Standards of proficiency. Dietitians Standards of proficiency Dietitians 1 Contents Foreword 3 Introduction 5 Standards of proficiency 9 2 Foreword We are pleased to present the Health and Care Professions Council s standards of proficiency

More information

Patient Handbook on Stem Cell Therapies

Patient Handbook on Stem Cell Therapies Patient Handbook on Stem Cell Therapies WWW.ISSCR.ORG WWW.CLOSERLOOKATSTEMCELLS.ORG Patient Handbook on Stem Cell Therapies Introduction We have all heard about the extraordinary promise that stem cell

More information

Frameworks for Ethical and Policy Analysis. CSCE 390: Professional Issues in Computer Science and Engineering Professor Matt Thatcher

Frameworks for Ethical and Policy Analysis. CSCE 390: Professional Issues in Computer Science and Engineering Professor Matt Thatcher Frameworks for Ethical and Policy Analysis CSCE 390: Professional Issues in Computer Science and Engineering Professor Matt Thatcher Last Time Course Administration Course website (Blackboard)» https://blackboard.sc.edu

More information

Assistant Manager, Social Work (New position)

Assistant Manager, Social Work (New position) Edmonton Catholic Schools is now accepting applications for the position of Assistant Manager, Social Work (New position) Edmonton Catholic Schools is a large urban school district whose mission is to

More information

Int. J. Pharm. Sci. Rev. Res., 31(2), March April 2015; Article No. 04, Pages: A Review on Drug Approval in Regulated and Non-Regulated Markets

Int. J. Pharm. Sci. Rev. Res., 31(2), March April 2015; Article No. 04, Pages: A Review on Drug Approval in Regulated and Non-Regulated Markets Review Article A Review on Drug Approval in Regulated and Non-Regulated Markets Vemuri Pavan Kumar, N Vishal Gupta* Pharmaceutical Quality Assurance Group, Department of Pharmaceutics, JSS College of Pharmacy,

More information

ETHICAL ASPECTS OF MEDICAL RESEARCH INVOLVING HUMAN SUBJECTS. ds Eric Koster MA

ETHICAL ASPECTS OF MEDICAL RESEARCH INVOLVING HUMAN SUBJECTS. ds Eric Koster MA ETHICAL ASPECTS OF MEDICAL RESEARCH INVOLVING HUMAN SUBJECTS ds Eric Koster MA Barcelona, June 3, 2015 eurordis.org 1 The need for assessment of medical research involving human subjects (1) 1900: Walter

More information

What is an IRB (Institutional Review Board)?

What is an IRB (Institutional Review Board)? What is an IRB (Institutional Review Board)? The Belmont Report The Belmont Report on the Ethical Principles and Guidelines for the Protection of Human Subjects of Research was prepared by the National

More information

ISPE Comments on the CIOMS 2006 draft Special Ethical Considerations for Epidemiologic Research 1

ISPE Comments on the CIOMS 2006 draft Special Ethical Considerations for Epidemiologic Research 1 Epidemiologic Research 1 December 12, 2006 Comments on 2006 CIOMS draft Special Ethical Considerations for Epidemiologic Research as proposed supplement to the updated 2002 CIOMS International Ethical

More information

Social Workers PLACEMENT Registration

Social Workers PLACEMENT Registration STANDARDS OF PROFICIENCY AND PRACTICE Social Workers PLACEMENT Registration FOR ADMISSION INTO MEMBERSHIP OF; Institute of Social Work of Nigeria (Established under CAP 59 OF 1990) As stipulated on ISOWN

More information

ONLINE PUBLIC CONSULTATION

ONLINE PUBLIC CONSULTATION DRAFT RECOMMENDATION OF THE COUNCIL ON PUBLIC INTEGRITY ONLINE PUBLIC CONSULTATION DEADLINE FOR COMMENT 22 MARCH 2016 The draft Recommendation of the Council on Public Integrity has been elaborated by

More information

Reporting Results and Incidental Findings to Research Participants

Reporting Results and Incidental Findings to Research Participants Reporting Results and Incidental Findings to Research Participants Jeffrey R Botkin, MD, MPH Professor of Pediatrics Chief, Division of Medical Ethics and Humanities Associate Vice President for Research

More information

Research Ethics Governance Policy

Research Ethics Governance Policy Research Office Research Ethics Governance Policy University of West London: Research Office, June 2008 Updated June 2015. Please note: 1. The information given in this publication is accurate at the time

More information

NOT PROTECTIVELY MARKED. Stop and Search Improvement Plan 2016/17 Code Phase III. 1 Version 2.0 October 2016 NOT PROTECTIVELY MARKED

NOT PROTECTIVELY MARKED. Stop and Search Improvement Plan 2016/17 Code Phase III. 1 Version 2.0 October 2016 NOT PROTECTIVELY MARKED Stop and Search Improvement Plan 2016/17 Code Phase III 1 Version 2.0 October 2016 (Code Phase III) Version 0.1 January 2016 Version History of Amendments Date 2.00 Addition to Training Needs Analysis

More information

Review of EU Clinical Trial Directive. 15 May 2012 Mike Beckers Sidley Austin LLP, Brussels

Review of EU Clinical Trial Directive. 15 May 2012 Mike Beckers Sidley Austin LLP, Brussels BEIJING BRUSSELS CHICAGO DALLAS FRANKFURT GENEVA HONG KONG LONDON LOS ANGELES NEW YORK PALO ALTO SAN FRANCISCO SHANGHAI SINGAPORE SYDNEY TOKYO WASHINGTON, D.C. Review of EU Clinical Trial Directive 15

More information

Regulatory and ethical requirements in medical device studies. Finland

Regulatory and ethical requirements in medical device studies. Finland Regulatory and ethical in medical device studies Finland SECTIONS A.Type of research SECTIONS A.Type of research We have differentiated 8 types of research: Medical device alone with CE mark use within

More information

Trends in Oversight of Human Research Protections?

Trends in Oversight of Human Research Protections? Trends in Oversight of Human Research Protections? Greg Koski, PhD, MD Associate Professor, Harvard Medical School Senior Scientist, James Mongan Institute for Health Policy Former Director, Office for

More information

Ethics Review Ethical Considerations of the Past & Present. Olivia Hart, MPA, CIP

Ethics Review Ethical Considerations of the Past & Present. Olivia Hart, MPA, CIP Ethics Review Ethical Considerations of the Past & Present Olivia Hart, MPA, CIP Research Ethics: Historical Events Monster Study: 1939 Termed the Monster Study by peers of the PI, Wendell Johnson from

More information

Building the Professional Capabilities Framework (7 th Feb 2012)

Building the Professional Capabilities Framework (7 th Feb 2012) Building the Professional Capabilities Framework (7 th Feb 2012) 1. Professionalism: Identify and behave as a professional social worker, committed to professional development END OF QUALIFYING LEVEL 1.1

More information

1.4 Applicable Regulatory Requirement(s) Any law(s) and regulation(s) addressing the conduct of clinical trials of investigational products.

1.4 Applicable Regulatory Requirement(s) Any law(s) and regulation(s) addressing the conduct of clinical trials of investigational products. 1.1 Adverse Drug Reaction (ADR) In the pre-approval clinical experience with a new medicinal product or its new usages, particularly as the therapeutic dose(s) may not be established: all noxious and unintended

More information

Hospital Authority (HA) Guide on Research Ethics (for Study Site & Research Ethics Committee)

Hospital Authority (HA) Guide on Research Ethics (for Study Site & Research Ethics Committee) Page 1 of 8 Hospital Authority (HA) Guide on Research Ethics (for Study Site & Version Effective Date 2 01/02/2015 Document Number HAHO-CE&TM-HA REC Author HA Head Office Steering Committee on Research

More information

Primary Care mcta 2013: Guidance for use

Primary Care mcta 2013: Guidance for use GUIDANCE ON USE OF THE MODEL CLINICAL TRIAL AGREEMENT FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY SPONSORED RESEARCH IN PRIMARY CARE (PRIMARY CARE mcta, 2013 VERSION) Background to the development

More information

MRC. Clinical Trials. Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS. Medical Research Council

MRC. Clinical Trials. Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS. Medical Research Council MRC Clinical Trials Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 Medical Research Council MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 MRC GUIDELINES FOR

More information

1. Checklist for Grant of permission to manufacture/import of Bulk Drug already approved in the country

1. Checklist for Grant of permission to manufacture/import of Bulk Drug already approved in the country 1. Checklist for Grant of permission to manufacture/import of Bulk Drug already approved in the country S no 1. Name of Applicant with address 2. Name of Drug 3. Therapeutic Class 4. Date of Approval Documents

More information

THE GLOBAL CODE OF INTEGRITY FOR LABOUR INSPECTION

THE GLOBAL CODE OF INTEGRITY FOR LABOUR INSPECTION THE GLOBAL CODE OF INTEGRITY FOR LABOUR INSPECTION ASSOCIATION INTERNATIONALE DE L INSPECTION DU TRAVAIL INTERNATIONAL ASSOCIATION OF LABOUR INSPECTION ASOCIACION INTERNACIONAL DE LA INSPECCION DE TRABAJO

More information

The Research Excellence Framework

The Research Excellence Framework The Research Excellence Framework Assessment framework, guidance on submissions and panel criteria Presentation outline Overview REF panels Staff Outputs Impact Environment 1 Overview: Purpose of the REF

More information

Pharmacovigilance. Dr. Ganesh Uchit, MD Pfizer, India

Pharmacovigilance. Dr. Ganesh Uchit, MD Pfizer, India Pharmacovigilance 1 Dr. Ganesh Uchit, MD Pfizer, India DISCLAIMER The presentation is intended for educational purposes only and does not replace independent professional judgement. Statements of fact

More information

Research: Ethics, Informed Consent, FDA, Off Label Use

Research: Ethics, Informed Consent, FDA, Off Label Use Research: Ethics, Informed Consent, FDA, Off Label Use Nasim Hedayati, MD, FACS, RPVI Assistant Professor Division of Vascular and Endovascular Surgery University of California, Davis 2015 Phlebology Review

More information

Guiding Principles on the Sharing of Clinical Trial Data. DNDi POLICIES

Guiding Principles on the Sharing of Clinical Trial Data. DNDi POLICIES Guiding Principles on the Sharing of Clinical Trial Data DNDi POLICIES May 2017 I. Preamble DNDi s vision is to improve the quality of life and health of people suffering from neglected tropical diseases

More information

International Transfers of Personal Data at sanofi-aventis R & D

International Transfers of Personal Data at sanofi-aventis R & D International Transfers of Personal Data at sanofi-aventis R & D Pierre-Yves Lastic, PhD Senior Director, Standards Management & Data Privacy Sanofi-aventis R&D CONFERENCE ON INTERNATIONAL TRANSFERS OF

More information

European Medicines Agency Perspective

European Medicines Agency Perspective European Medicines Agency Perspective WMA Workshop on revision of DoH, 4-6 Dec 2012, Capetown, South Africa. Presented by: Fergus Sweeney, PhD Head of Sector, Compliance and Inspection, European Medicines

More information

Staff Code of Conduct (Version 1.0)

Staff Code of Conduct (Version 1.0) DRAFT COPY Staff Code of Conduct (Version 1.0) POLICY STAFF CODE OF CONDUCT NVR Ref: Standard 2 MCC Ref: Policy MCC-2-S1 This Code of Conduct is intended to guide the staff of the Institute to identify

More information

Institutional Review Board for the Protection of Human Subjects

Institutional Review Board for the Protection of Human Subjects University of Michigan Deep Blue deepblue.lib.umich.edu 2012-10-16 Institutional Review Board for the Protection of Human Subjects Rosenzweig, Merle; Zeylikovich, Irina http://hdl.handle.net/2027.42/94130

More information

Chin Koerner Executive Director US Regulatory and Development Policy

Chin Koerner Executive Director US Regulatory and Development Policy Chin Koerner Executive Director US Regulatory and Development Policy Novartis Pharmaceuticals Corporation 1700 Rockville Pike Suite 510 Rockville, MD 20852 Tel 301.468.5607 Fax 301.468.5614 Email: Chin.Koerner@novartis.com

More information

Supervision guide for mental health and addiction kaiwhakahaere/ managers TEMPLATES. February 2015

Supervision guide for mental health and addiction kaiwhakahaere/ managers TEMPLATES. February 2015 Supervision guide for mental health and addiction kaiwhakahaere/ managers TEMPLATES February 2015 1 CONTENTS CONTENTS...2 Supervision process checklist... 3 Supervision contract templates... 4 Supervision

More information

A notice on the issuance of drug clinical trials, ethical review of the guiding principles

A notice on the issuance of drug clinical trials, ethical review of the guiding principles 药物临床试验伦理审查工作指导原侧.doc 的翻译 A notice on the issuance of drug clinical trials, ethical review of the guiding principles State Food and Drug Administration Note [2010] No. 436 November 2, 2010 Release A notice

More information

ETHICAL ISSUES IN CANCER CLINICAL TRIALS

ETHICAL ISSUES IN CANCER CLINICAL TRIALS ETHICAL ISSUES IN CANCER CLINICAL TRIALS ROSEMARY MAKAR, M.D. ABSTRACT Results from cancer clinical trials make valuable contributions to medical care for cancer patients. Two important ethical dilemmas

More information

Policy Position. Pharmacy-mediated interchangeability for Similar Biotherapeutic Products (SBPs)

Policy Position. Pharmacy-mediated interchangeability for Similar Biotherapeutic Products (SBPs) Pharmacy-mediated interchangeability for Similar Biotherapeutic Products (SBPs) Geneva, April 2016 Appropriate use of biotherapeutics including SBPs - SBPs, also known as biosimilars, are developed to

More information

Quality Management System. Manual MASTER COPY

Quality Management System. Manual MASTER COPY Quality Management System Manual MASTER COPY Revisions: Date Summary Rev. July 2010 14 Oct 2010 28 Jan 2011 9 Feb 2011 9 June 2011 6 March 2012 11 July 2013 13 July 2017 Initial Draft Issued Minor changes

More information

Availability of Masked and De-identified Non-Summary Safety and Efficacy Data; Request for

Availability of Masked and De-identified Non-Summary Safety and Efficacy Data; Request for This document is scheduled to be published in the Federal Register on 06/04/2013 and available online at http://federalregister.gov/a/2013-13083, and on FDsys.gov 4160-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Joint statement on public disclosure of results from clinical trials

Joint statement on public disclosure of results from clinical trials Joint statement on public disclosure of results from clinical trials Signatories on 18 May 2017 European Commission for Horizon 2020 Societal Challenge Health Demographic Change and Wellbeing (joined on

More information

Central Drugs Standard Control Organization Dte.GHS, Ministry of Health and Family Welfare, Gov ernment of India

Central Drugs Standard Control Organization Dte.GHS, Ministry of Health and Family Welfare, Gov ernment of India Central Drugs Standard Control Organization Dte.GHS, Ministry of Health and Family Welfare, Gov ernment of India Home Site Map Archive Feedback Downloads Contact FOREWORD Good Clinical Practices For Clinical

More information

Institutional Review Board (IRB)

Institutional Review Board (IRB) Institutional Review Board (IRB) Melissa Miklos Program Manager miklosm@upmc.edu Institutional Review Board What is the IRB? Why does the IRB exist? Where is the IRB? Who is the IRB? When do you need the

More information

Resource Tool for Non-government Drug and Alcohol Organisations

Resource Tool for Non-government Drug and Alcohol Organisations Resource Tool for Non-government Drug and Alcohol Organisations EQuIP 4 Resource Tool for Non Government Drug and Alcohol Organisations: August 2009 ACHS Copyright 2 Introduction EQuIP and Non-government

More information